We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments. Authors can upload supporting documentation to indicate the use of appropriate reporting guidelines for health-related
Sample-size estimation
 You should state whether an appropriate sample size was computed when the study was being designed  You should state the statistical method of sample size computation and any required assumptions  If no explicit power analysis was used, you should describe how you decided what sample (replicate) size (number) to use
Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Replicates  You should report how often each experiment was performed  You should include a definition of biological versus technical replication  The data obtained should be provided and sufficient information should be provided to indicate the number of independent biological and/or technical replicates  If you encountered any outliers, you should describe how these were handled  Criteria for exclusion/inclusion of data should be clearly stated  High-throughput sequence data should be uploaded before submission, with a private link for reviewers provided (these are available from both GEO and ArrayExpress)
Explicit power analysis was not used in the entire manuscript. Sample size estimation is not required for biochemistry and imaging analysis. For Western blotting, immunoprecipitation and sub-cellular fractionation each sample was prepared from a lysate of over million cells, as described in methods and figure legends. 2-5 independent biological samples were analyzed for each data set presented. Sample size and replicates are mentioned. In most cases we used n=3 or higher.
Cells were seeded and treated independently for each biological replicate. In case samples of the same biological replicates were used more than once, these are considered technical replicates. Data were collected from 2-5 biological replicates as mentioned. Unless there was a technical error, data were not excluded. Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
(For large datasets, or papers with a very large number of statistical tests, you may upload a single table file with tests, Ns, etc., with reference to sections in the manuscript.)
Group allocation  Indicate how samples were allocated into experimental groups (in the case of clinical studies, please specify allocation to treatment method); if randomization was used, please also state if restricted randomization was applied  Indicate if masking was used during group allocation, data collection and/or data analysis Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Additional data files ("source data")  We encourage you to upload relevant additional data files, such as numerical data that are represented as a graph in a figure, or as a summary table  Where provided, these should be in the most useful format, and they can be uploaded as "Source data" files linked to a main figure or table  Include model definition files including the full list of parameters used  Include code used for data analysis (e.g., R, MatLab)  Avoid stating that data files are "available upon request" Please indicate the figures or tables for which source data files have been provided:
The Students T-test was used to compare differences between data points. Statistical significances were described. Values from biological replicates were plotted together with standard error of the mean (SEM). SEM are shown as error bars of each graph.
Samples were allocated into a specific group based on the treatment used (chemical treatments) and genotypes. This is indicated in the Figure legends.
Full scans of Western blots were provided as supplementary files.
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